Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Early research (Phase 1)Study completedNCT00487786What this trial is testingSafety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder CancerWho this might be right forNeoplasms Achieve Life Sciences 64
Early research (Phase 1)Study completedNCT04580485What this trial is testingINCB106385 Alone or in Combination With Immunotherapy in Advanced Solid TumorsWho this might be right forOvarian CancerBladder CancerNon Small Cell Lung Cancer+8 more Incyte Corporation 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Post-approval studies (Phase 4)Study completedNCT02001857What this trial is testingEffect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.Who this might be right forProstate or Bladder Cancer University Hospital, Ghent 200
Testing effectiveness (Phase 2)Study completedNCT05253053What this trial is testingTo Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more TransThera Sciences (Nanjing), Inc. 84
Testing effectiveness (Phase 2)Study completedNCT02552121What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+4 more Seagen Inc. 33
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Early research (Phase 1)Active Not RecruitingNCT03582475What this trial is testingPembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateWho this might be right forBladder Small Cell Neuroendocrine CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Bladder Urothelial Carcinoma+14 more Jonsson Comprehensive Cancer Center 15
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Ended earlyNCT04066894What this trial is testingSacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyWho this might be right forLow Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more M.D. Anderson Cancer Center 3
Not applicableUnknownNCT06152679What this trial is testingDay-case Endourology; Patient ExperienceWho this might be right forBladder CancerBladder Outflow Obstruction Royal Devon and Exeter NHS Foundation Trust 15
Not applicableStudy completedNCT02785887What this trial is testingImpact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology PatientsWho this might be right forBreast CancerLung CancerOvarian Cancer+3 more Azienda USL 4 Prato 233
Early research (Phase 1)Study completedNCT03454451What this trial is testingCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersWho this might be right forNon-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more Corvus Pharmaceuticals, Inc. 117
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT00942331What this trial is testingGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerWho this might be right forAdvanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Prostate Carcinoma+10 more National Cancer Institute (NCI) 506
Testing effectiveness (Phase 2)Looking for participantsNCT06678126What this trial is testingAdaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)Who this might be right forProstate Cancer Scott Tyldesley 104
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24